Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
How to manage neuropathic pain
Neuropathic pain is defined as ‘pain caused by a lesion or disease of the somatosensory nervous system’.1
It is associated with impaired quality of...
Australian pharmacists on the world stage
PSA is learning from global colleagues and sharing the success of Australian pharmacy at the 79th Federation of International Pharmacists (FIP) World Congress of...
New COVID-19 case in Byron Bay means limited restrictions are back
Queensland recorded three new cases of COVID-19 today (31 March), as residents of Greater Brisbane wait to hear if they will spend the Easter break in lockdown.
Complementary medicine: Osteoarthritis
Pain caused by osteoarthritis (OA) is a common presentation in a community pharmacy, with many patients seeking advice on complementary and alternative medicines that...
A first line treatment option for cows’ milk allergy
Cows’ milk allergy (CMA) is one of the most common causes of food allergy in babies, affecting 1 in 50 Australian infants.1 As first...
Just what the pharmacist ordered
Pharmacist prescribing is ‘imminent’, says PSA National President Dr Shane Jackson. So what could that mean for you and your patients?
Pharmacists will have...
